Healthcare provider profile · identity verified

Kyle Lawson, MD

Internal Medicine · PORTLAND, OR · NPI 1174054720

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	325	97
Amlodipine Besylate	Amlodipine Besylate	165	54
Losartan Potassium	Losartan Potassium	159	55
Lisinopril	Lisinopril	141	35
Gabapentin	Gabapentin	122	33
Levothyroxine Sodium	Levothyroxine Sodium	111	33
Metformin Hcl Er	Metformin Hcl	109	31
Omeprazole	Omeprazole	105	38
Tamsulosin Hcl	Tamsulosin Hcl	95	31
Ozempic	Semaglutide	81	17
Eliquis	Apixaban	78	23
Trazodone Hcl	Trazodone Hcl	78	24
Pantoprazole Sodium	Pantoprazole Sodium	69	suppressed
Metformin Hcl	Metformin Hcl	68	21
Hydrochlorothiazide	Hydrochlorothiazide	67	22
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	67	17
Oxycodone Hcl	Oxycodone Hcl	63	20
Metoprolol Succinate	Metoprolol Succinate	61	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	57	29
Rosuvastatin Calcium	Rosuvastatin Calcium	53	18
Duloxetine Hcl	Duloxetine Hcl	52	14
Escitalopram Oxalate	Escitalopram Oxalate	49	16
Albuterol Sulfate Hfa	Albuterol Sulfate	48	25
Clopidogrel	Clopidogrel Bisulfate	43	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	43	13
Sertraline Hcl	Sertraline Hcl	41	11
Furosemide	Furosemide	40	suppressed
Tramadol Hcl	Tramadol Hcl	40	suppressed
Famotidine	Famotidine	37	suppressed
Montelukast Sodium	Montelukast Sodium	37	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	36	12
Pravastatin Sodium	Pravastatin Sodium	36	suppressed
Tizanidine Hcl	Tizanidine Hcl	28	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	27	12
Simvastatin	Simvastatin	26	suppressed
Bupropion Xl	Bupropion Hcl	24	suppressed
Potassium Chloride	Potassium Chloride	24	suppressed
Fluticasone Propionate	Fluticasone Propionate	22	14
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	18
Atenolol	Atenolol	21	suppressed
Finasteride	Finasteride	21	suppressed
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Hydrocortisone	Hydrocortisone	20	suppressed
Methocarbamol	Methocarbamol	20	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	20	20
Synthroid	Levothyroxine Sodium	20	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Alendronate Sodium	Alendronate Sodium	18	suppressed
Allopurinol	Allopurinol	18	suppressed
Ketoconazole	Ketoconazole	18	suppressed
Meloxicam	Meloxicam	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Donepezil Hcl	Donepezil Hcl	15	suppressed
Estradiol	Estradiol	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Jardiance	Empagliflozin	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Tresiba Flextouch U-100	Insulin Degludec	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Testosterone Cypionate	Testosterone Cypionate	14	suppressed
Alprazolam	Alprazolam	13	suppressed
Carvedilol	Carvedilol	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Topiramate	Topiramate	13	suppressed
Diazepam	Diazepam	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	12	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Naproxen	Naproxen	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	11
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Ramipril	Ramipril	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error